Ovarian Cancer

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Ovarian Cancer
Sep 9, 2024, 15:51 | Blog
4 symptomes that can improve the diagnosis of ovarian cancer by Shahrin Ahmed
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "The…
Sep 7, 2024, 14:50 | Blog
Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications
Medigene AG, an oncology platform company focused on the research and development of T cell…
Sep 6, 2024, 17:24 | Blog
We can’t always anticipate what happens to those we love but we can make a plan
American Cancer Society (ACS) shared on LinkedIn: “Lindsay O., an American Cancer Society volunteer, lost…
Sep 5, 2024, 14:50 | Insight
UAE’s first ovarian preservation procedure on a 7-year-old patient with ALL
MedEdge MEA shared a post on LinkedIn: “The Abu Dhabi Stem Cells Center (ADSCC) has…
Sep 5, 2024, 00:05 | Blog
September is Gynecologic Cancer Awareness Month - NRG Oncology
NRG Oncology made the following post on X: "September is Gynecologic Cancer Awareness Month, which includes…
Sep 4, 2024, 16:13 | Blog
September is Gynecologic Cancer Awareness Month 2024 - Meno Martha International Menopause Directory
Meno Martha International Menopause Directory shared a post on X: ''Gynecologic Cancer Awareness Month 2024.…
Sep 4, 2024, 11:18 | Insight
ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours
ESGO made the following post on X: "Published last night in The Lancet Oncology. Paper: ESGO-ESHRE-ESGE…
Sep 4, 2024, 03:51 | Blog
Antonio Giordano: National Gynecologic Cancer Awareness Month serves as a beacon, guiding us as a society to take actionable steps against these diseases
Antonio Giordano, President of Sbarro Health Research Organization, posted the following on LinkedIn: “National Gynecologic…
Sep 2, 2024, 17:54 | Blog
Today is the start of Gynecologic Cancer Awareness Month! - Uterine Cancer Awareness Network
Uterine Cancer Awareness Network made the following post on X: "Today is the start of Gynecologic…
Sep 2, 2024, 17:22 | Insight
Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer
Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…
Aug 26, 2024, 21:14 | Blog
Livnat Jerby: Applying spatial transcriptomics at subcellular resolution to 130 ovarian cancer tumors
Livnat Jerby, Assistant Professor at Stanford University, posted on X:  "Our new paper is out…
Aug 21, 2024, 14:03 | Blog
$3 million research grant to Dana-Farber Cancer Institute and UT Health San Antonio to study BRCA therapy
Dana-Farber Cancer Institute shared on LinkedIn: "Scientists at Dana-Farber's Center for BRCA and Related Genes in…
Aug 15, 2024, 15:01 | Blog
Exciting Breakthrough in Early Detection of Aggressive Ovarian Cancer - World Ovarian Cancer Coalition
World Ovarian Cancer Coalition shared a post on LinkedIn: “Exciting Breakthrough in Early Detection of…
Aug 10, 2024, 13:30 | Insight
Susanna Greer: Unzipping truths behind BRCA
Susanna Greer shared on LinkedIn: "The focus of this week’s Cool Cancer Find comes from…
Aug 9, 2024, 16:01 | Blog
Re-sensitizing cancer to previously effective treatments - Ovarian Cancer Research Alliance
Ovarian Cancer Research Alliance shared on X: “The potential for re-sensitizing cancer to previously effective…
Aug 6, 2024, 14:09 | Blog
DeepHRD predicts HRD from routine biopsy slides
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X,…
Aug 6, 2024, 01:14 | Blog
First-Line Maintenance Strategies for Ovarian Cancer with Bevacizumab and PARP Inhibitors - EIOC
Excellence in Oncology Care (EIOC) shared on X: "Save the Date! Join our virtual journal…
Aug 5, 2024, 05:34 | Dialogues
Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics
Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…
Aug 4, 2024, 11:36 | Blog
Updates about federal funding for key ovarian and gynecologic cancer programs at CDC - Ovarian Cancer Research Alliance
Ovarian Cancer Research Alliance shared a post on X: "Get important updates about federal funding for…
Jul 31, 2024, 15:50 | Blog
Juan Cubillos-Ruiz: Iron chelation therapy unleashes innate immune responses that control Ovarian Cancer
Juan Cubillos-Ruiz,  Associate Professor for Infection and Immunology at Well Corner Medicine, shared on X:…
Jul 31, 2024, 12:48 | Blog
Megan-Claire Chase: Cancer experience from a teenager's perspective
Megan-Claire Chase, A Patient Advocate, shared on LinkedIn: "As many of you know, I was…
Jul 21, 2024, 21:50 | Blog
Women with endometriosis have a significant increased risk of developing ovarian cancer
Huntsman Cancer Institute posted on X about recent paper by Jennifer Doherty et al., commenting: "A…
Jul 16, 2024, 15:29 | Insight
Delving into the topic of early detection for ovarian cancer with Sarah DeFeo and Gillian Hanley
Audra Moran, President and CEO at Ovarian Cancer Research Alliance (OCRA), shared on LinkedIn: “Fortune…
Jul 13, 2024, 15:20 | Blog
Rizwan Romee: CAR memory–like NK cells in ovarian cancer
Rizwan Romee, Associate Professor at Dana-Farber Cancer Institute, shared on X: "Excited to share this paper…
Jul 12, 2024, 23:39 | Blog
Itai Yanai: ‘Resistance continuum’ of resistant phenotypes of cancer cells
Itai Yanai, Professor at the Department of Biochemistry and Molecular Pharmacology at NYU, shared on…
Jul 7, 2024, 07:08 | Insight
Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jul 6, 2024, 14:18 | Blog
Zheng Wang: Tumor immune infiltration and prognosis in early breast cancer
Zheng Wang, Clinical Assistant Professor at Ruijin Hospital Affiliated to Shanghai Jiao Tong University, shared on…
Jul 6, 2024, 12:09 | Blog
An incredible outreach program organized by the Network of People Impacted by Cancer in Nigeria with Project PINK BLUE - Medicaid CF Programs
Quoting Medicaid CF Programs on X: "Throwback to the weekend where we were honored to…
Jul 1, 2024, 13:29 | Blog
Rodrigo Sánchez-Bayona: RWE study of ovarian cancer patients treated with PARP inhibitors at ESMO Gynaecological Cancers Congress 2024
Rodrigo Sánchez-Bayona, Medical Oncologist specialising in breast and gynecological cancers at 12 de Octubre University…
Jul 1, 2024, 12:34 | Blog
Ilaria Colombo: New targets and new drugs for the treatment of ovarian cancer at XXI MaNGO meeting
Ilaria Colombo, Medical Oncologist at MD. Drug Development and Gyne Cancer, posted on X: "Great…
Jun 29, 2024, 22:54 | Blog
Caitlin Delaney: The reality of living with a rare cancer
Caitlin Delaney, Chair of the National Patient Advisory Committee and Patient-Partnered Research at VCCC Alliance, shared…
Jun 24, 2024, 11:28 | Blog
Funding available in ovarian cancer research for mid-career physician scientists - Conquer Cancer Foundation
Conquer Cancer Foundation shared on LinkedIn:       . "Deadline extended! Funding available in ovarian…
Jun 24, 2024, 10:34 | Insight
Susanna Greer: Opening the door to new treatments for cancer patients
Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn:…
Jun 23, 2024, 18:37 | Blog
Monika Pansari: Positive transformation often lies on the other side
Monika Pansari, Senior Consultant Surgical Oncologist at Fortis Hospital, Bangalore posted on LinkedIn: "To those…
Jun 23, 2024, 13:36 | Blog
ESMO Daily Reporter article by Giovanni Scambia about Ginecological cancers
ESMO (European Society for Medical Oncology) shared on LinkedIn:             …
Jun 20, 2024, 01:53 | Insight
Miguel Bronchud: ESMO recommends performing tumour NGS to detect tumour-agnostic alterations in patients with metastatic cancers
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: “2024- ESMO of course recommends…
Jun 19, 2024, 12:33 | Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 14, 2024, 16:16 | Insight
Maximilian Strobl: Could adaptive therapy improve PARPi maintenance for ovarian cancer?
Maximilian Strobl, Postdoctoral Researcher at Moffitt Cancer Center and Research Institute, shared a post on…
Jun 14, 2024, 00:15 | Blog
Daria Afenteva: Poster session is ongoing at EACR2024 in Rotterdam!
Daria Afenteva, Doctoral Researcher at University of Helsinki, shared a post on X: "Poster session…
Jun 13, 2024, 01:46 | Insight
Dmitriy Zamarin: Submit your abstracts to the Biennial Rivkin-AACR Ovarian Cancer Research symposium!
Dmitriy Zamarin, Section Head of Gynecologic Medical Oncology at Icahn School of Medicine at Mount…
Jun 11, 2024, 15:36 | Blog
Jia Liu: Thrilled to share results from the Phase I/II clinical trial of dendrimer SN38
Jia Liu, Translational Lead, Early Phase Drug Development at The Kinghorn Cancer Centre and Conjoint…
Jun 10, 2024, 11:27 | Cancer Types
Primary Peritoneal Cancer: What patients should know about
Primary peritoneal cancer (PPC) is a rare and aggressive malignancy that originates in the peritoneum,…
Jun 5, 2024, 13:40 | Immune Oncology
Immunotherapy for Ovarian Cancer: A Growing Field
How Immunotherapy Works for Ovarian Cancer Immunotherapy represents a paradigm shift in the treatment of…
May 29, 2024, 14:37 | Blog
Antonio Giordano: 'International Dialogue on Ovarian Cancer, from Bench to Bedside' congress
Antonio Giordano, President of Sbarro Health Research Organization, posted the following on LinkedIn: "On May…
May 29, 2024, 07:57 | Insight
Khalid El Bairi: Don't forget to follow these wonderful oncologists, advocates, and researchers!
Khalid El Bairi, International Executive Council at NCODA shared a post on X: “Don't forget to…
May 26, 2024, 12:04 | Societies
Dee Sparacio: Join us and learn how social media improves practice, research and education!
Dee Sparacio, Ovarian Cancer Survivor, Author and Research Advocate, shared on X: "One week from…
May 23, 2024, 15:03 | Insight
Alexander Anderson: Our beautiful integrated Cell Systems paper led by the brilliant Maximilian Strobl
Alexander Anderson, Chair of Integrative Mathematical Oncology at Moffitt Cancer Center, shared on X: "Very…
May 22, 2024, 14:42 | Blog
eFFECTOR Therapeutics announces the initiation of an investigator-sponsored trial in collaboration with the Dana-Farber Cancer Institute
eFFECTOR Therapeutics shared a post on LinkedIn: "We are excited to announce the initiation of an…
May 22, 2024, 08:39 | Blog
Tanja Obradovic: ASCO just published guidelines for germline genetic testing panels
Tanja Obradovic shared on LinkedIn: "Great service to public and oncology community as ASCO just published…
May 17, 2024, 19:06 | Blog
Zainab Shinkafi-Bagudu: Global Coalition Urges World Health Leaders to Prioritise Ovarian Cancer in the Fight for Women's Health
Zainab Shinkafi-Bagudu shared on LinkedIn: “Global Coalition Urges World Health Leaders to Prioritise Ovarian Cancer in…
May 16, 2024, 16:51 | Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 16, 2024, 02:34 | Blog
Dr. Domenica Lorusso discussed the survival analysis of the PAOLA1 trial - International Journal of Gynecological Cancer
International Journal of Gynecological Cancer shared on LinkedIn: "New episode of Weekly Podcast Dr. Domenica…
May 15, 2024, 12:22 | Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 12, 2024, 08:07 | Blog
World Ovarian Cancer Coalition's petition to the WHO to recognize ovarian cancer as a global priority
World Ovarian Cancer Coalition shared on X: "While ovarian cancer can develop at any age,…
May 11, 2024, 10:21 | Blog
Fatima Dambatta: A petition to make ovarian cancer a global health priority
Fatima Dambatta, Medical Programs Manager at Medicaid Cancer Foundation, shared on LinkedIn: ''The first close-up…
May 11, 2024, 07:07 | Blog
Caitlin Delaney: Yet I am one of the lucky ones - on paper I shouldn't be here
Caitlin Delaney, Chair of the National Patient Advisory Committee, Patient-Partnered Research at VCCC Alliance, shared…
May 11, 2024, 01:43 | Blog
Nermean Mostafa: Be aware by Ovarian Cancer risk factors
Nermean Mostafa, Head of Clinical Oncology unit at Ain Shams University, shared a post on LinkedIn:…
May 10, 2024, 14:52 | Blog
$2.7 million NHMRC Investigator Grant in Ovarian Cancer research to Anna DeFazio - The Daffodil Centre
The Daffodil Centre shared on LinkedIn: "Congratulations to Anna DeFazio on securing a $2.7 million National…
May 7, 2024, 10:39 | Blog
Caryn Lerman: Saul Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research
Caryn Lerman, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:…
May 5, 2024, 22:49 | Blog
Rachel Riechelm and Álvaro Lopes de Oliveira discuss paragangliomas and pheochromocytoma - Tumor Board Tuesday
Tumor Board Tuesday shared on X: “No Tumor Board Tuesday this past week, so we're…
May 2, 2024, 15:20 | Blog
Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years
Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…
Apr 21, 2024, 17:24 | Insight
Piotr Wysocki: Only biliary tract and ovarian advanced cancer patients seem to benefit from next-generation sequencing
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 20, 2024, 08:16 | Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
Apr 18, 2024, 12:54 | Drugs
Volastra Therapeutics dosed the first ovarian cancer patient in a Phase 1b clinical trial for sovilnesib
Volastra Therapeutics shared a post on LinkedIn: "We are proud to announce that we dosed the…
Apr 17, 2024, 19:06 | Drugs
New research from Dr. Jung-Min Lee has identified a potential drug to treat ovarian cancers - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Milestones Monday: Ovarian cancer is the most lethal…
Apr 17, 2024, 11:33 | Drugs
Tanja Obradovic: What can we expect from antibody-drug conjugates (ADCs) in advanced ovarian cancer beyond Mirvetuximab?
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: “What…
Apr 16, 2024, 12:14 | Blog
Tracy Milgram: An incredible day at AYA with Sylvester Comprehensive Cancer Center
Tracy Milgram, Founder of BRCAStrong, shared on LinkedIn: "Today was an incredible day at AYA…
Apr 14, 2024, 06:53 | Societies
Sign this petition calling on the WHO and Health Leaders to take action on Ovarian Cancer - FLAC
First Ladies Against Cancer shared a post on X: "As First Ladies Against Cancer (FLAC), join…
Apr 9, 2024, 14:23 | Societies
World Ovarian Cancer Coalition Urges World Health Leaders to Prioritise Ovarian Cancer in the Fight for Women's Health
Quoting World Ovarian Cancer Coalition on LinkedIn: "Toronto, Canada, April 8, 2024 - In an…
Mar 28, 2024, 03:11 | Drugs
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post…
Mar 17, 2024, 20:05 | Blog
Ane Gerda Zahl Eriksson: Incredible effort from European Society of Gynaecological Oncology Accredited Centers
Ane Gerda Zahl Eriksson recently posted on LinkedIn: "Incredible effort from European Society of Gynaecological Oncology…
Mar 13, 2024, 17:05 | Blog
Meet CRCHD grantee Dr. Diane Mahoney, interested in studying factors that contribute to higher ovarian cancer death rates among Black women - NCI Center to Reduce Cancer Health Disparities (CRCHD)
Mar 11, 2024, 03:32 | Insight
The March issue of ONCOLOGY is available and ready to download - Cancer Network
Cancer Network shared on their X/Twitter: "The March issue of ONCOLOGY is available and ready…
Feb 12, 2024, 15:23 | Opinion
Piotr J. Wysocki: Do we finally have a promising screening method for ovarian cancer?
Piotr J. Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University…
Dec 27, 2023, 13:21 | Insight
First data showing overall survival benefit for PARPi maintenance for Ovarian Cancer - ACS Journal Cancer
ACS Journal Cancer posted on X/Twitter: "Just published! 'Top advances of the year: Ovarian Cancer'…
Dec 17, 2023, 03:29 | Blog
Advancing the Battle Against Platinum-Resistant Ovarian Cancer: Promising Strategies from 2023 ASCO & ESMO Meetings
The 2023 ASCO and ESMO meetings provided novel insights for treating platinum-resistant ovarian cancer, a…
Dec 11, 2023, 18:34 | Insight
Yüksel Ürün: Mirvetuximab Soravtansine (MIRV) shows promise in platinum-resistant ovarian cancer
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X/Twitter: ''Mirvetuximab Soravtansine (MIRV) shows promise…
Nov 3, 2023, 23:30 | Blog
The German Prize for Cancer Prevention Research - DKFZ German Cancer Research Center
DKFZ German Cancer Research Center, made the following post on LinkedIn: "Congratulations to Rita Schmutzler…
Oct 4, 2023, 18:26 | Insight
Julie Gralow: New ASCO recommendations on the need for collection of ovarian toxicity in cancer clinical trials!
Julie Gralow, shared a post by ASCO on X/Twitter, adding: "New ASCO recommendations on the…
Sep 30, 2023, 19:29 | Blog
Gemma Peters: This beautiful knitted cardigan and a Minion cuddly toy were surprise gifts I received today from one of our most dedicated supporters, Brian Herman.
Gemma Peters, CEO of Macmillan Cancer Support, recently posted on LinkedIn: "I’ve been adding some…
Sep 6, 2023, 18:32 | Blog
September is Ovarian Cancer Awareness Month.- Ovarcome
Quoting Ovarcome, on Twitter: "September is Ovarian Cancer Awareness Month. Join us to Teach The…
Aug 22, 2023, 09:18 | Blog
Hon. Jill Hennessy: Extraordinary breaking news from Hudson Research: a new blood test to transform ovarian cancer diagnosis is under development.
Quoting Hon. Jill Hennessy, Vice-Chancellors Professorial Fellow at Monash University, and former Attorney-General & Minister…
Aug 7, 2023, 07:17 | Blog
Promising strides in Ovarian Cancer research! - Henry Rodriguez
Promising strides in Ovarian Cancer research! CPTAC has identified a 64-protein signature that may predict…
Jul 8, 2023, 13:10 | Positive
Pro golfer Jill McGill is helping Ovarian Cancer Research Alliance raise awareness in honor of her sister, Shelley O’Keefe - Audra Moran
Pro golfer Jill McGill is helping Ovarian Cancer Research Alliance raise awareness in honor of her sister,…
All: 84 Posts: 1 - 100
Special Coverage